𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The use of adenoviral vectors for gene therapy and gene transfer in vivo

✍ Scribed by Jonathan L Bramson; Frank L Graham; Jack Gauldie

Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
584 KB
Volume
6
Category
Article
ISSN
0958-1669

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Successful gene therapy of the Gunn rat
Successful gene therapy of the Gunn rat by in vivo neonatal hepatic gene transfer using murine oncoretroviral vectors
✍ Marta Bellodi-Privato; Dominique Aubert; Virginie Pichard; Anne Myara; FranΓ§ois πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 250 KB

Crigler-Najjar type 1 disease (CN1) is a rare inherited metabolic disease characterized by complete absence of hepatic UDP-glucuronosyl transferase (UGT1), resulting in high levels of unconjugated bilirubin. CN1 is an attractive candidate disease for gene therapy. Here we show that in vivo neonatal

Encapsulated cells producing retroviral
Encapsulated cells producing retroviral vectors for in vivo gene transfer
✍ Robert M. Saller; Stefano Indraccolo; Vincenzo Coppola; Giovanni Esposito; Jan S πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 437 KB

## Abstract ## Background Because gene therapy of the future will primarily take an __in vivo__ approach, a number of problems associated with its current implementation exist. Currently, repeated delivery of a vector __in vivo__ is necessary to ensure adequate transfer of the therapeutic gene. Th